Source: LCGC

Auromedics: AuroMedics Pharma Issues Recall Due to Glass Particulates in Vials

On May 14, 2018, AuroMedics Pharma LLC announced it is voluntarily recalling two lots of Piperacillin and Tazobactam for injection, USP 3.375 g in a single-dose vial, to the hospital level. The recall comes after glass particulates were found within a vial. The affected product is pack

Read full article »
Est. Annual Revenue
$25-100M
Est. Employees
25-100
Ronald F Quadrel's photo - CEO of Auromedics

CEO

Ronald F Quadrel

CEO Approval Rating

73/100

Read more